MPTIMEDIUM SIGNALFINANCIAL10-K

MPTI reported solid operational growth with revenue increasing 11% while substantially expanding its balance sheet strength through meaningfully higher total assets and cash positions.

The company demonstrates healthy fundamental momentum with revenue growth translating into improved profitability and cash generation. The substantial increase in total assets and cash reserves suggests either successful capital raising activities or strong cash accumulation, positioning the company for potential growth investments or enhanced financial flexibility.

Comparing 2026-03-26 vs 2025-03-27View on EDGAR →
FINANCIAL ANALYSIS

MPTI delivered balanced growth across key metrics with revenue advancing 11% to $54.4M and net income rising 10.6% to $8.4M, while operating cash flow grew notably by 42% to $10.7M. The balance sheet strengthened considerably with total assets growing substantially to $68.4M and cash reserves expanding meaningfully to $20.9M, while debt levels declined modestly. This financial profile suggests a company generating solid operational results while building substantial financial resources for future opportunities.

FINANCIAL STATEMENT CHANGES
Total Assets
Balance Sheet
+87.4%
$36.5M$68.4M

Asset base grew 87.4% — expansion through organic growth, acquisitions, or capital deployment.

Cash & Equivalents
Balance Sheet
+65.3%
$12.6M$20.9M

Cash position surged 65.3% — strong cash generation or capital raise providing significant financial cushion.

Total Debt
Balance Sheet
-47.6%
$145K$76K

Debt reduced 47.6% — deleveraging strengthens balance sheet and reduces financial risk.

Operating Cash Flow
Cash Flow
+41.7%
$7.5M$10.7M

Operating cash flow surged 41.7% — exceptional cash generation, highest quality earnings signal.

Capital Expenditure
Cash Flow
+34.4%
$1.9M$2.6M

Capital expenditure jumped 34.4% — major investment cycle underway; assess returns on deployment.

R&D Expense
P&L
+12.5%
$2.8M$3.2M

R&D investment increased 12.5% — signals commitment to future product development, though near-term margin impact.

Revenue
P&L
+11%
$49.0M$54.4M

Revenue growing 11% — solid top-line momentum, watch margins for quality of growth.

Net Income
P&L
+10.6%
$7.6M$8.4M

Net income grew 10.6% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2026-03-26
PRIOR — 2025-03-27
ADDED
true true true false 204 182 0.01 0.01 5,000,000 5,000,000 0 0 0.01 0.01 25,000,000 25,000,000 3,405,210 3,405,210 2,911,165 2,911,165 1 4 4 0 0 0 8 2 48 0 0 0 http://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMember 0 560,140 1 5 http://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrent false false false false true false As of December 31, 2025 and 2024 , included investments in money market mutual funds managed or advised by GAMCO Investors, Inc.
For the year ended December 31, 2025, Florida and Massachusetts made up the majority (greater than 50%) of the tax effect in this category.
For the year ended December 31, 2024, Florida and Massachusetts made up the majority (greater than 50%) of the tax effect in this category.
Because there is insufficient historical stock price data for the Company over the expected term of the options granted, the expected volatility is based on the implied volatility of the Company's historical stock price data (from date of IPO to grant date) appended with the implied volatility of LGL Group's historical stock price data (pre-IPO stock price through the IPO date) blended with the implied volatility of the Company's peers' stock price data (over the entire expected term).
The expected term is the simple average of the vesting period (3 years) and the contractual term (5 years).
Other segment items includes the following: Interest income Income received under the Amended and Restated Transitional Administrative and Management Services Agreement with LGL Group Foreign currency gains and losses Expense reimbursements paid to / received from LGL Group.
Of the total $143 net deferred tax assets as of December 31, 2025, $272 was included in Deferred income tax asset and ($129) was included in Deferred income tax liability on the Consolidated Balance Sheets.
Of the total $1,623 net deferred tax asset as of December 31, 2024, $1,695 was included in Deferred income tax asset and ($72) was included in Deferred income tax liability on the Consolidated Balance Sheets.
Treasury zero-coupon rate over the four days prior to the grant date.
We chose the risk-free rate that is commensurate with the length of the remaining performance period as of the grant date and interpolated between the yields of the three-year and five-year rates to determine the yield.
REMOVED
The number of outstanding shares of the registrant's common stock was 2,911,165 as of March 14, 2025.
Mtron's primary markets are aerospace and defense, space, and avionics.
Mtron's production facility in India operates under a Manufacturing License Agreement ("MLA") issued by the U.S.
Our common stock is traded on the NYSE American ("NYSE") under the symbol "MPTI." Mtron ' s Separation On October 7, 2022, the separation of the Mtron business from The LGL Group, Inc.
These devices may be based on quartz, quartz micro-electromechanical systems ("MEMS") or advanced materials science designed to achieve higher performance levels than quartz.
Integrated Microwave Assembly Mtron s Integrated Microwave Assembly ("IMA") products brings over 60 years of expert crystal, filter and oscillator design experience to our Custom Multi-Functional Modules ("MFM") and Integrated Microwave Assemblies.
The IMA product group designs and develops solutions using the same circuit, electromagnetic, mechanical, thermal, and stress analysis tools as our customers, which allows Mtron s MFM and IMA design synthesis to be effortlessly integrated into the customer s system synthesis at early stages in the development process.
The IMA product group also reviews all build-to-print opportunities, utilizing all our in-house assembly and test capabilities to competitively support this service.
Our competitive strategy begins with our focus on niche markets where highly engineered performance and reliability are the major requirements.
Research and development expense was $2,809 and $2,216 for the years ended December 31, 2024 and 2023, respectively, and will remain a significant part of the Company's efforts to continually enhance its intellectual property position.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →